Joshua Ellenhorn, M.D.

South Pasadena, CA
General Oncologic Surgery

EDUCATION AND TRAINING:
Medical School: Boston University School of Medicine
Board Certification: Surgery

 

 

Practicing Locations:

SUMMARY:
Joshua D.I. Ellenhorn, MD is one of City of Hope Cancer Center's leading experts in Surgical Oncology, specializing in surgical treatments for cancers of the gastrointestinal tract and head and neck. He is also a leading educator, serving as both Director of Surgical Education at City of Hope and Director of City of Hope's Surgical Oncology Fellowship Program. A nationally recognized leader in surgical oncology, surgical education, and cancer research, Dr. Ellenhorn is dedicated to providing the highest quality of surgical care with an emphasis on a personalized approach to the individual patient.
Dr. Ellenhorn joined the City of Hope medical staff in 1993. His many achievements include pioneering the use of minimally invasive and robotic techniques to treat gastrointestinal malignancies. In addition to his clinical and educational work, Dr. Ellenhorn runs an active research laboratory at City of Hope. His laboratory is working to develop and evaluate new cancer vaccines that can stimulate the immune system to identify and eliminate cancer cells. The goal of this research, funded by grants from the National Institutes of Health (NIH) and a number of other research organizations, is to develop a vaccine to eliminate tumors in patients with cancer.
Dr. Ellenhorn has received numerous citations for his work, including fellowship awards from the NIH and from the American Cancer Society. He has published more than 75 book chapters, abstracts and articles in peer-reviewed journals, and delivered dozens of presentations at medical conferences worldwide. He is a member of the editorial boards of a number of oncologic and surgical journals and has been a member of a number of national panels defining guidelines for state of the art cancer care. He is a current member of the NIH Clinical Oncology Study Section which makes decisions about future clinical cancer trials throughout the United States.
Prior to his arrival at City of Hope in 1993, he completed his residency at the University of Cincinnati Hospital , and performed fellowship training for two years in immunology at the University of Chicago . He completed a two-year surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York. He received his medical degree from the Boston University School of Medicine.